SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : VISX
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: cheeseboy who wrote (440)3/14/1998 11:25:00 PM
From: Vector1  Read Replies (1) of 1754
 
Cheeseboy,
Excellent post. An number of institutional investors are beginning to follow the sequential quarterly revenue growth at the larger vision centers. This is probably the single largest reason for VISX's run the Paine Webber report notwithstanding. PW has has a strong buy out on the company for some time and Charles O has written numerous positive reports. When the stock was trading in the high teens he was as perplexed as everyone else.
In many respects VISX has been tarnished by the battles with Summit. Frankly, other than the lawsuit Summit is largely irrelevent. Laser eye surgery is here to stay and VISX is the best capitalized company, has a significant installed base and professional management. I think it is likely that we will see 50 before year end.
V1
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  

HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2025 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News